Search research articles
Contact Us
Filters
Showing results (51-60 of 178) with videos related to
Page
of 18
Sort By:
Journal of Neuro-Oncology
|
April 24, 2008
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
A Tosoni, E Franceschi, M Ermani, et al.
Expert Review of Anticancer Therapy
|
August 26, 2021
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light
Ilaria Maggio, Enrico Franceschi, Lidia Gatto, et al.
Critical Reviews in Oncology/Hematology
|
March 24, 2009
Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET)
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
CNS Oncology
|
May 21, 2021
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, et al.
Anticancer Research
|
January 30, 2003
Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients
Franco Lumachi, Mario Ermani, Alba A Brandes, et al.
Immunotherapy
|
November 30, 2017
Immunotherapy in head and neck cancer: evidence and perspectives
Alicia Tosoni, Enrico Franceschi, Ernesto Pasquini, et al.
Anti-Cancer Drugs
|
August 4, 2021
Immune-checkpoint inhibitors in pituitary malignancies
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Cancer Treatment Reviews
|
June 23, 2012
Optimal management of elderly patients with glioblastoma
Normand Laperriere, Michael Weller, Roger Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2009
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status
Alba A Brandes, Alicia Tosoni, Enrico Franceschi, et al.
Nature Reviews. Neurology
|
December 10, 2009
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller, Roger Stupp, Guido Reifenberger, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 178) with videos related to
Sort By:
Page
of 18
Journal of Neuro-Oncology
|
April 24, 2008
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
A Tosoni, E Franceschi, M Ermani, et al.
Expert Review of Anticancer Therapy
|
August 26, 2021
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light
Ilaria Maggio, Enrico Franceschi, Lidia Gatto, et al.
Critical Reviews in Oncology/Hematology
|
March 24, 2009
Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET)
Alba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
CNS Oncology
|
May 21, 2021
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, et al.
Anticancer Research
|
January 30, 2003
Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients
Franco Lumachi, Mario Ermani, Alba A Brandes, et al.
Immunotherapy
|
November 30, 2017
Immunotherapy in head and neck cancer: evidence and perspectives
Alicia Tosoni, Enrico Franceschi, Ernesto Pasquini, et al.
Anti-Cancer Drugs
|
August 4, 2021
Immune-checkpoint inhibitors in pituitary malignancies
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Cancer Treatment Reviews
|
June 23, 2012
Optimal management of elderly patients with glioblastoma
Normand Laperriere, Michael Weller, Roger Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2009
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status
Alba A Brandes, Alicia Tosoni, Enrico Franceschi, et al.
Nature Reviews. Neurology
|
December 10, 2009
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller, Roger Stupp, Guido Reifenberger, et al.
Page
of 18